Goodman Advisory Group’s Pfizer PFE Stock Holding History

Goodman Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.2K	Hold	614	–	–	﹤0.01%	137
2025 Q4	$15.3K	Hold	614	–	–	﹤0.01%	133
2025 Q3	$15.6K	Hold	614	–	–	﹤0.01%	136
2025 Q2	$14.9K	Hold	614	–	–	0.01%	112
2025 Q1	$15.6K	Buy	+614	New	+$16.1K	﹤0.01%	141
2024 Q4	–	Sell	-614	Closed	-$17.8K	–	143
2024 Q3	$17.8K	Hold	614	–	–	0.01%	149
2024 Q2	$17.2K	Hold	614	–	–	0.01%	144
2024 Q1	$17K	Hold	614	–	–	0.01%	123
2023 Q4	$17.7K	Sell	614 -25,240	-98%	-$763K	0.01%	112
2023 Q3	$858K	Sell	25,854 -228,592	-90%	-$8.08M	0.32%	50
2023 Q2	$9.33M	Buy	254,446 +253,832	+41,341%	+$9.88M	3.46%	6
2023 Q1	$25.1K	Hold	614	–	–	0.01%	93
2022 Q4	$31K	Hold	614	–	–	0.02%	86
2022 Q3	$27K	Hold	614	–	–	0.01%	89
2022 Q2	$32K	Buy	+614	New	+$31.3K	0.01%	88

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Goodman Advisory Group's PFE Position: Q1 2026 in Review

Goodman Advisory Group held its Pfizer (PFE) position steady in Q1 2026 at 614 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #137.

Goodman Advisory Group first reported a position in PFE in Q2 2022 and has held it in 15 quarters since. The position peaked at $9.33M in Q2 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Goodman Advisory Group held 614 shares of Pfizer worth $17.2K as of Q1 2026.
Goodman Advisory Group left its Pfizer share count unchanged in Q1 2026.
Pfizer made up ﹤0.01% of Goodman Advisory Group's portfolio in Q1 2026, its #137 holding.
Goodman Advisory Group first reported a position in Pfizer in Q2 2022 and has held it in 15 quarters since.
Goodman Advisory Group's Pfizer position peaked at $9.33M in Q2 2023.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Goodman Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.